Investors Buy Dow Chemical (DWDP) on Weakness After Insider Selling

Investors purchased shares of Dow Chemical Company (The) (NYSE:DWDP) on weakness during trading on Tuesday following insider selling activity. $183.99 million flowed into the stock on the tick-up and $86.68 million flowed out of the stock on the tick-down, for a money net flow of $97.31 million into the stock. Of all companies tracked, Dow Chemical had the 11th highest net in-flow for the day. Dow Chemical traded down ($0.59) for the day and closed at $71.54Specifically, insider Jeanmarie F. Desmond sold 6,708 shares of Dow Chemical stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $71.01, for a total transaction of $476,335.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Andrew N. Liveris sold 187,402 shares of Dow Chemical stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $72.23, for a total value of $13,536,046.46. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 377,982 shares of company stock valued at $27,120,766. Insiders own 0.89% of the company’s stock.

Several analysts recently weighed in on the company. Macquarie assumed coverage on Dow Chemical in a report on Tuesday, September 5th. They set an “outperform” rating and a $76.00 price target for the company. Nomura raised their price objective on Dow Chemical from $77.00 to $82.00 and gave the stock a “buy” rating in a research note on Wednesday, September 13th. started coverage on Dow Chemical in a research note on Tuesday, September 26th. They set a “hold” rating on the stock. Monness Crespi & Hardt started coverage on Dow Chemical in a research note on Tuesday, September 12th. They set a “neutral” rating on the stock. Finally, Stephens started coverage on Dow Chemical in a research note on Monday. They set an “overweight” rating and a $83.00 price objective on the stock. One research analyst has rated the stock with a sell rating, five have given a hold rating and nineteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $79.89.

The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.38 and a current ratio of 2.01. The stock has a market cap of $166,162.69, a P/E ratio of 19.40, a PEG ratio of 2.38 and a beta of 1.15.

Dow Chemical (NYSE:DWDP) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.55 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.55. Dow Chemical had a return on equity of 9.73% and a net margin of 5.01%. The company had revenue of $18.29 billion for the quarter, compared to analyst estimates of $18.24 billion. During the same quarter last year, the company posted $0.91 EPS. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. sell-side analysts forecast that Dow Chemical Company will post 3.36 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 15th. Stockholders of record on Wednesday, November 15th will be paid a $0.38 dividend. The ex-dividend date is Tuesday, November 14th. This represents a $1.52 annualized dividend and a dividend yield of 2.12%. Dow Chemical’s payout ratio is 73.08%.

Institutional investors and hedge funds have recently modified their holdings of the company. Excalibur Management Corp bought a new position in shares of Dow Chemical in the 3rd quarter valued at $303,000. TCI Wealth Advisors Inc. bought a new position in shares of Dow Chemical in the 3rd quarter valued at $973,000. Gilman Hill Asset Management LLC bought a new position in shares of Dow Chemical in the 3rd quarter valued at $1,088,000. Barometer Capital Management Inc. bought a new stake in Dow Chemical during the 3rd quarter worth $4,701,000. Finally, Mechanics Bank Trust Department bought a new stake in Dow Chemical during the 3rd quarter worth $1,450,000. Institutional investors own 68.81% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Investors Buy Dow Chemical (DWDP) on Weakness After Insider Selling” was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://www.chaffeybreeze.com/2017/12/06/investors-buy-dow-chemical-dwdp-on-weakness-after-insider-selling.html.

About Dow Chemical

DowDuPont Inc is a holding company formed through the merger of equals between The Dow Chemical Company and E. I. du Pont de Nemours and Company (DuPont). The Company’s business divisions include Agriculture division, Material Science division, and a Specialty Products division. The Agriculture Division offers a complete portfolio of products and technologies, traits and crop protection.

Receive News & Ratings for Dow Chemical Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dow Chemical Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply